SCHEMBL6326696

SCHEMBL6326696

CCCCCn1c(C)cc2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.58
KMT2A Q03164 6/20 0.58
KDM4E B2RXH2 3/20 0.58
ALDH1A1 P00352 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
GAA P10253 1/20 0.58
TP53 P04637 4/20 0.55
TSHR P16473 2/20 0.55
MAPT P10636 4/20 0.50
TLR8 Q9NR97 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
HTT P42858 1/20 0.50
NPC1 O15118 1/20 0.50
HSP90AA1 P07900 1/20 0.50
PKM P14618 1/20 0.50
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30151601 1.00 MEN1 (0.58) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL11605849 0.98 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL11607968 0.98 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL31022025 0.98 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9275476 0.98 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL11607923 0.98 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL10412457 0.98 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL10413247 0.98 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL11153101 0.98 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL4212491 0.98 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118459448-A 3, 3-Bis (N-alkyl-2-methylindole) phthalides and preparation method and application thereof 苏州韦恩斯生物科技有限公司 2024-08-09 CN disclosed
US-20050009903-A1 CB2-selective cannabinoid analogues CLEMSON UNIVERSITY 2005-01-13 US disclosed
US-4525588-A FOR HEAT AND PRESSURE SENSITIVE RECORDING MATERIALS CIBA GEIGY CORPORATION (US) 1985-06-25 US disclosed
US-4102893-A Process for the manufacture of color formers of indoles and anhydrides of aromatic or heteroaromatic, vicinal dicarboxylic acids, new color formers of these classes of substance and their use CIBA-GEIGY AG (CH) 1978-07-25 US disclosed
US-4022802-A INDOLES, ALKALI HYDROXIDE; ALKYLATION CIBA-GEIGY AG (CH) 1977-05-10 US disclosed
US-3969346-A Naphtholactamcarbinols color formers, their manufacture and use in pressure-sensitive or thermoreactive recording material CIBA-GEIGY CORPORATION (US) 1976-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009903-A1 CB2-selective cannabinoid analogues CNR2, CNR1, GPR68 MEN1 1930/4885KMT2A 886/4885KDM4E 2063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.